Cosmos Health Inc. (COSM)
NASDAQ: COSMHealth CareOther PharmaceuticalsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
COSM stock chart
Technical analysisKey statistics
All statistics- Market cap
- $14.14M
- Forward P/E
- 40.14
- EPS (TTM)
- -$13.00
- Dividend yield
- None
- 52-week range
- 2.20 – 14.36
- Day range
- 2.55 – 3.25
- Volume / Avg
- 140.14K / 163.51K
- Beta
- —
- Shares outstanding
- 5.03M
52-week range
COSM stock today
Cosmos Health (COSM) closed at $2.81 on Nov 20, down 2.09% (-$0.06), versus the S&P 500's 3.70% decline. At this level, COSM sits near the bottom of its 52-week range of $2.20 to $14.36: 80.4% below the high and 27.7% above the low. COSM is up 464.3% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 314.5%.
Cosmos Health has posted a net loss over the last twelve months (EPS of -$13.00), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Cosmos Health
Company profileCosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, the United Arab Emirates, Albania, North Macedonia, and Cyprus. The company provides prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names.
- Sector
- Health Care
- Industry
- Other Pharmaceuticals
- CEO
- Mr. Grigorios Siokas
- Headquarters
- Thessaloniki
- Employees
- 163
- Website
- cosmoshealthinc.com
Financial highlights
Full financialsIn fiscal 2025, Cosmos Health generated $65.3 million in revenue, up 19.9% from fiscal 2024, its 3rd consecutive year of revenue growth. Cosmos Health reported a net loss of $19.1 million, compared with a loss of $16.2 million a year earlier. Gross margin was 12.1% (up from 7.9%) and operating margin -25.6%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $65.27M | $54.43M | $53.38M | $50.35M | $56.24M |
| Growth | +19.93% | +1.97% | +6.02% | -10.48% | +1.50% |
| Net income | $-19.14M | $-16.18M | $-18.54M | $-13.83M | $-7.96M |
| EPS (diluted) | $-0.63 | $-1.17 | $-2.15 | $-33.16 | $-23.74 |
Analyst forecast
ForecastConsensus
strong_buy
Avg. price target
$4.50+60.14%
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 20, 2026
- EPS actual vs est.
- $-3.40 vs $-0.80
- Surprise
- -325.00%
Cosmos Health peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| MEDSDataMeds AI Inc. | 1.34 | +84.14% | $7.67M | vs COSM |
| HKPDCellyan Biotechnology Co. Ltd Class A | 1.38 | +2.60% | $3.40M | vs COSM |
| ESYNEnerSyn Global Inc. | 1.11 | -0.89% | $37.44M | vs COSM |
| NUSNu Skin Enterprises Inc. | 3.80 | +0.80% | $184.98M | vs COSM |
| HLFHerbalife Ltd. | 15.53 | -0.26% | $1.63B | vs COSM |
| CAHCardinal Health Inc. | 272.81 | +0.17% | $63.06B | vs COSM |
| CORCencora Inc. | 339.09 | -0.63% | $64.71B | vs COSM |
| MCKMcKesson Corporation | 1,069.43 | +0.68% | $123.47B | vs COSM |
Indexes, lists and sector
Cosmos Health stock FAQ
What is Cosmos Health's stock price today?
COSM last traded at $2.81 as of Nov 20, 4:00 PM EST, down 2.09% on the day. Prices are delayed at least 15 minutes.
Does Cosmos Health pay a dividend?
No. Cosmos Health does not currently pay a regular cash dividend.
Who is Cosmos Health's CEO?
Mr. Grigorios Siokas is the chief executive officer of Cosmos Health Inc., which has about 163 employees.
Has COSM ever split its stock?
Yes. The most recent COSM stock split was a 1-for-20 split on Nov 13, 2026, one of 2 splits on record.
What is the COSM 52-week high?
The 52-week high for COSM is $14.36 and the 52-week low is $2.20. The stock is currently 80.4% below its high.